Invesco’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.02M | Buy |
424,027
+34,322
| +9% | +$730K | ﹤0.01% | 1839 |
|
|
2025
Q1 | $7.52M | Sell |
389,705
-9,345
| -2% | -$180K | ﹤0.01% | 1947 |
|
|
2024
Q4 | $7.12M | Buy |
399,050
+324,555
| +436% | +$5.79M | ﹤0.01% | 2048 |
|
|
2024
Q3 | $1.63M | Buy |
74,495
+2,818
| +4% | +$61.7K | ﹤0.01% | 2684 |
|
|
2024
Q2 | $559K | Sell |
71,677
-3,800
| -5% | -$29.6K | ﹤0.01% | 3218 |
|
|
2024
Q1 | $312K | Buy |
75,477
+5,448
| +8% | +$22.6K | ﹤0.01% | 3498 |
|
|
2023
Q4 | $183K | Sell |
70,029
-5,570
| -7% | -$14.5K | ﹤0.01% | 3575 |
|
|
2023
Q3 | $141K | Buy |
75,599
+531
| +0.7% | +$993 | ﹤0.01% | 3657 |
|
|
2023
Q2 | $188K | Buy |
75,068
+62,084
| +478% | +$156K | ﹤0.01% | 3613 |
|
|
2023
Q1 | $22.7K | Buy |
+12,984
| New | +$22.7K | ﹤0.01% | 3790 |
|
|
2022
Q2 | – | Sell |
-11,273
| Closed | -$28K | – | 4095 |
|
|
2022
Q1 | $28K | Buy |
11,273
+584
| +5% | +$1.45K | ﹤0.01% | 3933 |
|
|
2021
Q4 | $28K | Sell |
10,689
-8,478
| -44% | -$22.2K | ﹤0.01% | 3977 |
|
|
2021
Q3 | $96K | Buy |
19,167
+3,028
| +19% | +$15.2K | ﹤0.01% | 3913 |
|
|
2021
Q2 | $120K | Buy |
+16,139
| New | +$120K | ﹤0.01% | 3845 |
|